Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

H2020

VISION DMD

Project reference: 667078
Funded under

VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy

From 2016-01-01 to 2019-12-31, ongoing project

Project details

Total cost:

EUR 15 997 949,77

EU contribution:

EUR 6 000 000

Coordinated in:

United Kingdom

Call for proposal:

H2020-PHC-2015-two-stageSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Related information

Open Access

Coordinator

UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom

EU contribution: EUR 2 190 532,06


KINGS GATE
NE1 7RU NEWCASTLE UPON TYNE
United Kingdom

Participants

Reveragen Biopharma Limited
United Kingdom

EU contribution: EUR 0


The Oaks, 3 Village Road
CH48 3JN West Kirby
United Kingdom
STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY
Netherlands

EU contribution: EUR 320 000


KONINGINNELAAN 69
3905 GG VEENENDAAL
Netherlands
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
France

EU contribution: EUR 1 985 648,73


5 RUE WATT
75013 PARIS
France
CERATIUM LIMITED
United Kingdom

EU contribution: EUR 442 344,26


THE HAVEN 20 BURLINGHAM AVENUE
CH48 8AP WEST KIRBY
United Kingdom
FAKULTNI NEMOCNICE V MOTOLE
Czech Republic

EU contribution: EUR 265 312,5


V UVALU 84
150 06 PRAHA 5
Czech Republic
Children's Research Institute (CRI)
United States

EU contribution: EUR 796 162,45


Michigan Avenue 111
20010 Washington, DC
United States
Record Number: 199721 / Last updated on: 2016-07-04